key: cord-0054140-3bn3nw80
authors: Novazzi, Federica; Cassaniti, Irene; Piralla, Antonio; Di Sabatino, Antonio; Bruno, Raffaele; Baldanti, Fausto; Mondelli, M; Brunetti, E; Di Matteo, A; Seminari, E; Maiocchi, L; Zuccaro, V; Pagnucco, L; Mariani, B; Ludovisi, S; Lissandrin, R; Parisi, A; Sacchi, P; Patruno, SFA; Michelone, G; Gulminetti, R; Zanaboni, D; Novati, S; Maserati, R; Orsolini, P; Vecchia, M; Sciarra, M; Asperges, E; Colaneri, M; Di Filippo, A; Sambo, M; Biscarini, S; Lupi, M; Roda, S; Pieri, TC; Gallazzi, I; Sachs, M; Valsecchi, P; Perlini, S; Alfano, C; Bonzano, M; Briganti, F; Crescenzi, G; Falchi, AG; Guarnone, R; Guglielmana, B; Maggi, E; Martino, I; Pettenazza, P; Pioli di Marco, S; Quaglia, F; Sabena, A; Salinaro, F; Speciale, F; Zunino, I; De Lorenzo, M; Secco, G; Dimitry, L; Cappa, G; Maisak, I; Chiodi, B; Sciarrini, M; Barcella, B; Resta, F; Moroni, L; Vezzoni, G; Scattaglia, L; Boscolo, E; Zattera, C; Tassi, MF; Capozza, V; Vignaroli, D; Bazzini, M; Iotti, G; Mojoli, F; Belliato, M; Perotti, L; Mongodi, S; Tavazzi, G; Marseglia, G; Licari, A; Brambilla, I; Barbarini, D; Bruno, A; Cambieri, P; Campanini, G; Cavanna, C; Comolli, G; Corbella, M; Daturi, R; Furione, M; Mariani, B; Marone, P; Maserati, R; Monzillo, E; Paolucci, S; Parea, M; Percivalle, E; Rovida, F; Sarasini, A; Zavattoni, M; Adzasehoun, G; Ardizzone, M; Bellotti, L; Brunco, V; Cabano, E; Casali, G; Capella, L; Devitis, D; Dossena, L; Frisco, G; Garbagnoli, G; Gardellini, F; Girello, A; Guerrizio, A; Landini, V; Lucchelli, C; Maliardi, V; Piemontese, P; Pezzaia, S; Premoli, M; Rebuffa, C; Zanello, C; Bagnarino, J; Bergami, F; Bonetti, A; Caneva, G; Corcione, A; Di Martino, R; Di Napoli, A; Ferrari, A; Ferrari, G; Fiorina, L; Gallone, A; Giardina, F; Girardi, A; Mercato, A; Ratano, G; Rossi, B; Saveriaempillai, G; Sciabica, IM; Tallarita, M; Vecchio Nepita, E; Vitali, J; Cerino, A; Varchetta, S; Oliviero, B; Mantovani, S; Mele, D; Calvi, M; Tizzoni, M; Nicora, C; Triarico, A; Petronella, V; Marena, C; Muzzi, A; Lago, P; Cutti, S; Novelli, V; Comandatore, F; Batisti Biffignandi, G; Gaiarsa, S; Rettani, M; Bandi, C; Ferrari, A
title: Detection of the SARS‐CoV‐2 in different biologic specimens from positive patients with COVID‐19, in Northern Italy
date: 2020-11-24
journal: Pediatr Allergy Immunol
DOI: 10.1111/pai.13366
sha: a5c9354ad7a86b2629ef81b560beba6ab449e1f3
doc_id: 54140
cord_uid: 3bn3nw80

Coronavirus disease 2019 (COVID‐19) diagnosis is based on molecular detection of SARS‐CoV‐2 in respiratory samples such as nasal swab (NS). However, the evidence that NS in patients with pneumonia was sometimes negative raises the attention to collect other clinical specimens. SARS‐CoV‐2 was shown in 10.3% rectal swabs (RS), 7.7% plasma, 1% urine, and 0% feces from 143 NS‐positive patients. Potential infection by fluids different from respiratory secretion is possible but unlikely.

However, the evidence that NS in patients with COVID-19 pneumonia was sometimes negative raises the attention to collect other clinical specimens that may be useful for etiologic diagnosis since bronchoalveolar lavage (BAL) collection is not always possible. 4 In the present study, we examined the presence of SARS-CoV-2 RNA in multiple biologic specimens collected simultaneously to respiratory samples from COVID-19 patients in order to determine the detec- Median and range were given for quantitative variables, while qualitative variables were shown as percentages or frequencies.

A total of 366 specimens corresponding to 143 consecutive patients were examined. In detail, 11/107 (10.3%) patients had a COVID-19-positive RS, 2/26 (7.7%) patients had a COVID-19positive plasma, while only 1/85 (1.2%) had a COVID-19-positive urine sample. None of the 5 stool specimens tested positive.

The median viral load detected in respiratory samples was 4 × 10 6 copies/ml (range 1.7-6.9), while it was 4.1 × 10 6 copies/ml (range 1.7-6.5) in RS and 2.9 × 10 6 copies/ml (range 2.9-3) in two positive plasma (Table 1) . The most common clinical features of hospitalized patients with COVID-19 were fever, dry cough, dyspnea, diarrhea, asthenia, and respiratory disorders as pneumonia and sore throat.

None of the 116 specimens (59 NS, 18 urine, and 39 RS), from 59 COVID-19-negative control patients, tested positive.

The transmission of SARS-CoV-2 through direct contact with infected secretion or aerosol droplets is well known. 5 However, in the past epidemics caused by other coronaviruses (SARS-CoV-1 and MERS-CoV), viral RNA was also detected in several clinical specimens such as 42% urine, 97% stool, and 50% plasma. [6] [7] [8] In this respect, these materials have been considered as useful clinical samples to improve laboratory diagnosis. Also, the possibility of different SARS-CoV-2 transmission routes could be contemplated. In this brief report, we described the presence of the virus in different clinical samples, including RS, plasma, and urine, supporting the evidence of a potential shed of the virus through fecal-oral or body fluid routes.

In this study, the highest rate of positive RT-PCR for SARS-CoV-2 was detected in RS specimens (10.3%), suggesting that SARS-CoV-2 may be transmitted by the fecal route. 5 However, this rate is lower than SARS-CoV-1.

Focusing on plasma samples, we reported only a few cases of positive RNA detection in plasma (7.7%), but higher than that reported by Wang et al, 5 suggesting a systemic infection can occur although less frequently with respect to 50% SARS-CoV-1. 9 The SARS-CoV-2 was rarely detected in urine, and to date, no 

The authors have no conflicts of interest to declare. 

Coronavirus disease 2019 (COVID-19) in Italy

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Negative nasopharyngeal and oropharyngeal swab does not rule out COVID-19

Detection of SARS-CoV-2 in different types of clinical specimens

Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways

Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus

Find the right sample: A study on the versatility of saliva and urine samples for the diagnosis of emerging viruses

Detection of severe acute respiratory syndrome coronavirus RNA in plasma during the course of infection

Baldanti F; for the San Matteo Pavia COVID-19 Task Force. Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19

The San Matteo Pavia COVID-19 Task Force